FM

Frank Martin

AM Amgen: 1 patents #139 of 377Top 40%
EL E.R. Squibb & Sons, L.L.C.: 1 patents #15 of 45Top 35%
Overall (2016): #401,040 of 481,213Top 85%
1
Patents 2016

Issued Patents 2016

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
9260514 Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors Kenneth D. Wild, Jr., James Treanor, Haichun Huang, Heather Inoue, Tie J. Zhang 2016-02-16